Prognostic significance of location and type of myocardial infarction: independent adverse outcome associated with anterior location

Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02115.

To determine the relative prognostic significance of location (anterior or inferior) and type (Q wave or non-Q wave) of infarction, the hospital course and follow-up outcome (mean duration 30.8 months) of 471 patients with a first infarction were analyzed. Analyses were performed grouping the patients according to infarct location (anterior, n = 253; inferior, n = 218), infarct type (Q wave, n = 323; non-Q wave, n = 148), and both location and type (inferior non-Q wave, n = 85; inferior Q wave, n = 133; anterior non-Q wave, n = 63; and anterior Q wave, n = 190). Patients with anterior infarction had a substantially worse in-hospital and follow-up clinical course compared with those with inferior infarction, evidenced by a larger infarct size (21.2 versus 14.9 g Eq/m2 creatine kinase, MB fraction [MB CK], p less than 0.001), lower admission left ventricular ejection fraction (38.1 versus 55.3%, p less than 0.001) and higher incidence of heart failure (40.7 versus 14.7%, p less than 0.001), serious ventricular ectopic activity (70.2 versus 58.9%, p less than 0.05), in-hospital death (11.9 versus 2.8%, p less than 0.001) and total cumulative cardiac mortality (27 versus 11%, p less than 0.001). Patients with Q wave infarction similarly experienced a worse in-hospital course compared with patients with non-Q wave infarction, evidenced by a larger infarct size (20.7 versus 12.7 MB CK g Eq/m2, p less than 0.001), lower admission left ventricular ejection fraction (43.7 versus 50.6%, p less than 0.001), and a higher incidence of heart failure (31.9 versus 21.6%, p less than 0.05) and in-hospital death (9.3 versus 4.1% p less than 0.05). However, there was no increased rate of reinfarction or mortality in hospital survivors with non-Q wave infarction compared with those with Q wave infarction, and total cardiac mortality was similar (16 versus 21%, p = NS). To evaluate the role of infarct location and type independent of infarct size, patients were grouped according to quartile of infarct size, and outcome was reanalyzed within each group. Patients with anterior infarction demonstrated a lower left ventricular ejection fraction on admission and after 10 days than did patients with inferior infarction, even after adjustment for infarct size, as well as a higher incidence of congestive heart failure and cumulative cardiac mortality.(ABSTRACT TRUNCATED AT 400 WORDS)

This article has been cited by other articles:

				O. Gjesdal, T. Helle-Valle, E. Hopp, K. Lunde, T. Vartdal, S. Aakhus, H.-J. Smith, H. Ihlen, and T. Edvardsen Noninvasive Separation of Large, Medium, and Small Myocardial Infarcts in Survivors of Reperfused ST-Elevation Myocardial Infarction: A Comprehensive Tissue Doppler and Speckle-Tracking Echocardiography Study Circ Cardiovasc Imaging, November 1, 2008; 1(3): 189 - 196. [Abstract] [Full Text] [PDF]

				H. S. Lim, G. Y.H. Lip, and H.-F. Tse Implantable cardioverter defibrillator following acute myocardial infarction: the '48-hour' and '40-day' rule Europace, May 1, 2008; 10(5): 536 - 539. [Abstract] [Full Text] [PDF]

				K. Lunde, S. Solheim, S. Aakhus, H. Arnesen, M. Abdelnoor, T. Egeland, K. Endresen, A. Ilebekk, A. Mangschau, J. G. Fjeld, et al. Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction. N. Engl. J. Med., September 21, 2006; 355(12): 1199 - 1209. [Abstract] [Full Text] [PDF]

				B. M. Jackson, L. M. Parish, J. H. Gorman III, Y. Enomoto, H. Sakamoto, T. Plappert, M. G. St. John Sutton, I. Salgo, and R. C. Gorman Borderzone Geometry After Acute Myocardial Infarction: A Three-Dimensional Contrast Enhanced Echocardiographic Study Ann. Thorac. Surg., December 1, 2005; 80(6): 2250 - 2255. [Abstract] [Full Text] [PDF]

				A. Kashani, R. P. Giugliano, E. M. Antman, D. A. Morrow, C. M. Gibson, S. A. Murphy, and E. Braunwald Severity of heart failure, treatments, and outcomes after fibrinolysis in patients with ST-elevation myocardial infarction Eur. Heart J., October 1, 2004; 25(19): 1702 - 1710. [Abstract] [Full Text] [PDF]

				J. C. C. Moon, D. Perez De Arenaza, A. G. Elkington, A. K. Taneja, A. S. John, D. Wang, R. Janardhanan, R. Senior, A. Lahiri, P. A. Poole-Wilson, et al. The pathologic basis of Q-wave and non-Q-wave myocardial infarction: A cardiovascular magnetic resonance study J. Am. Coll. Cardiol., August 4, 2004; 44(3): 554 - 560. [Abstract] [Full Text] [PDF]

				R. Lampert, C. A. McPherson, J. F. Clancy, T. L. Caulin-Glaser, L. E. Rosenfeld, and W. P. Batsford Gender differences in ventricular arrhythmia recurrence in patients with coronary artery disease and implantable cardioverter-defibrillators J. Am. Coll. Cardiol., June 16, 2004; 43(12): 2293 - 2299. [Abstract] [Full Text] [PDF]

				E. F. Lewis, L. A. Moye, J. L. Rouleau, F. M. Sacks, J. M. O. Arnold, J. W. Warnica, G. C. Flaker, E. Braunwald, and M. A. Pfeffer Predictors of late development of heart failure in stable survivors of myocardial infarction: The CARE study J. Am. Coll. Cardiol., October 15, 2003; 42(8): 1446 - 1453. [Abstract] [Full Text] [PDF]

				D. S.H. Bell Heart Failure: The frequent, forgotten, and often fatal complication of diabetes Diabetes Care, August 1, 2003; 26(8): 2433 - 2441. [Abstract] [Full Text] [PDF]

				A. H. Wu, L. Parsons, N. R. Every, and E. R. Bates Hospital outcomes in patients presenting with congestive heart failure complicating acute myocardial infarction: A report from the Second National Registry of Myocardial Infarction (NRMI-2) J. Am. Coll. Cardiol., October 16, 2002; 40(8): 1389 - 1394. [Abstract] [Full Text] [PDF]

				G. W. Stone, M. A. Peterson, A. J. Lansky, G. Dangas, R. Mehran, and M. B. Leon Impact of normalized myocardial perfusion after successful angioplasty in acute myocardial infarction J. Am. Coll. Cardiol., February 20, 2002; 39(4): 591 - 597. [Abstract] [Full Text] [PDF]

				J Herlitz, B W Karlson, M Sjolin, and J Lindqvist Ten year mortality in subsets of patients with an acute coronary syndrome Heart, October 1, 2001; 86(4): 391 - 396. [Abstract] [Full Text] [PDF]

				J Abdulla, B Brendorp, C Torp-Pedersen, L Kober, and on behalf of the TRACE study group Does the electrocardiographic presence of Q waves influence the survival of patients with acute myocardial infarction? Eur. Heart J., June 2, 2001; 22(12): 1008 - 1014. [Abstract] [PDF]

				E. Garcia, J. Elizaga, N. Perez-Castellano, J. A. Serrano, J. Soriano, M. Abeytua, J. Botas, R. Rubio, E. Lopez de Sa, J. L. Lopez-Sendon, et al. Primary angioplasty versus systemic thrombolysis in anterior myocardial infarction J. Am. Coll. Cardiol., March 1, 1999; 33(3): 605 - 611. [Abstract] [Full Text] [PDF]

				L. E. Rohde, M. Aikawa, G. C. Cheng, G. Sukhova, S. D. Solomon, P. Libby, J. Pfeffer, M. A. Pfeffer, and R. T. Lee Echocardiography-derived left ventricular end-systolic regional wall stress and matrix remodeling after experimental myocardial infarction J. Am. Coll. Cardiol., March 1, 1999; 33(3): 835 - 842. [Abstract] [Full Text] [PDF]

				S. T. Kelley, R. Malekan, J. H. Gorman III, B. M. Jackson, R. C. Gorman, Y. Suzuki, T. Plappert, D. K. Bogen, M. G. St. J. Sutton, and L. H. Edmunds Jr Restraining Infarct Expansion Preserves Left Ventricular Geometry and Function After Acute Anteroapical Infarction Circulation, January 12, 1999; 99(1): 135 - 142. [Abstract] [Full Text] [PDF]

				U. Zeymer, K.-L. Neuhaus, K. Wegscheider, U. Tebbe, P. Molhoek, R. Schroder, and for the HIT-4 Trial Group Effects of thrombolytic therapy in acute inferior myocardial infarction with or without right ventricular involvement J. Am. Coll. Cardiol., October 1, 1998; 32(4): 876 - 881. [Abstract] [Full Text] [PDF]

				K. L. Lee, L. H. Woodlief, E. J. Topol, W. D. Weaver, A. Betriu, J. Col, M. Simoons, P. Aylward, F. Van de Werf, and R. M. Califf Predictors of 30-Day Mortality in the Era of Reperfusion for Acute Myocardial Infarction : Results From an International Trial of 41 021 Patients Circulation, March 15, 1995; 91(6): 1659 - 1668. [Abstract] [Full Text]

				E. Ambrosioni, C. Borghi, B. Magnani, and The Survival of Myocardial Infarction Long-Term Ev The Effect of the Angiotensin-Converting-Enzyme Inhibitor Zofenopril on Mortality and Morbidity after Anterior Myocardial Infarction N. Engl. J. Med., January 12, 1995; 332(2): 80 - 85. [Abstract] [Full Text] [PDF]